The Resurrection of Myeloperoxidase as a Therapeutic Target
Main Author: | Angela M. Taylor, MD, MS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | JACC: Basic to Translational Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452302X16301590 |
Similar Items
-
The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
by: Yan G, et al.
Published: (2021-04-01) -
Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
by: Muhammad Ali, MD, et al.
Published: (2016-12-01) -
Association between serum myeloperoxidase levels and coronary artery disease in patients without diabetes, hypertension, obesity, and hyperlipidemia
by: Zahra Hasanpour, et al.
Published: (2016-01-01) -
The role of myeloperoxidase as a diagnostic and prognostic factor in cardiovascular pathology (acute coronary syndrome)
by: M. P. Kopytsia, et al.
Published: (2021-10-01) -
Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina
by: Mehdi Baseri, et al.
Published: (2014-01-01)